CTRI/2016/05/006958已完成未知
To evaluate efficacy and safety of Amphotericin B in two different doses (0.5 mg/kg Vs 1 mg/ kg) in the treatment of Post Kala-Azar Dermal Leishmaniasis (PKDL)
Intramural Projects of RMRIMS ICMR0 个研究点目标入组 50 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Both sex patients aged 5-60 years
- •Parasitologically confirmed Post kala azar
- •dermal leishmaniasis (PKDL)
- •All types of PKDL
排除标准
- •Pregnant and lactating females.
- •Patients not willing to participate.
- •Individuals who were sero positive for HIV
- •Individuals with a serious concurrent
- •infection (e.g., tuberculosis or bacterial
- •pneumonia) were excluded from the study.
- •Thrombocyte count <100 x 109/l
- •Leukocyte count <2.5 x 109/l
- •Hemoglobin < 6.0 g/100 ml
- •ASAT, ALAT, AP >3 times upper limit of normal
- •Bilirubin >2 times upper limit of normal
- •HbsAg, HCV and HIV positive
- •Serum creatinine or BUN >1.5 times upper
- •limit of normal range
研究者
相似试验
已完成
不适用
Comparison of side effect associated with amphotericin B deoxycholate infusion 24hrs vs 4hrs in trauma icu patients.CTRI/2019/02/017813Deptt of Anaesthesiology60
已完成
不适用
to evaluate the efficacy of amphotericin B injection in trearment of cutaneous leishmaniasis.Cutaneous Leishmaniasis.Cutaneous LeishmaniasisIRCT201105223862N7Research council of mashhad University of Medical Sciences.90
已完成
不适用
Clinical Effectiveness and Safety of Amphotericin B With Flucytosine-Fluconazole Therapy for Cryptococcal MeningitisCryptococcal MeningitisNCT04532463University of Pharmacy, Yangon30
已完成
2 期
iposomal amphotericin B for the treatment of Nepalese patients with visceral leishmaniasis.Visceral LeishmaniasisInfection - Other infectious diseasesACTRN12610000130066The United Nations Children's Fund (UNICEF)/ The United Nations Development Programme (UNDP) /World Bank /World Health Organization (WHO) Special Programme for Research and Training in Tropical Diseases (TDR)35
进行中（未招募）
2 期
iposomal amphotericin B for the treatment of Bangladeshi patients with visceral leishmaniasis.ACTRN12609001029280The United Nations Children's Fund (UNICEF)/ The United Nations Development Programme (UNDP) /World Bank /World Health Organization (WHO) Special Programme for Research and Training in Tropical Diseases (TDR)35